Department of Psychology, University of Arizona, Tucson, USA
Mini Review
TMS for Chemotherapy-related Cognitive Impairment
Author(s): Carol Chen*
Cancer is a formidable adversary that affects millions of people worldwide. Over the years, advancements in cancer treatment have improved
survival rates, offering hope to many. However, chemotherapy, one of the most common treatment modalities, comes with its own set of
challenges. Chemotherapy-related cognitive impairment, often referred to as "chemo brain," is a well-documented and distressing side effect that
can significantly impact a patient's quality of life. In recent years, Transcranial Magnetic Stimulation (TMS) has emerged as a promising tool to
mitigate the cognitive deficits associated with chemotherapy. This article explores the role of TMS in addressing chemotherapy-related cognitive
impairment, its mechanisms, current research findings and potential implications. Chemotherapy-related cognitive impairment is a multifaceted
condition cha.. Read More»
DOI:
10.37421/2684-4583.2023.6.209
Journal of Brain Research received 2 citations as per Google Scholar report